Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Benefits reported for exemestane as first-line treatment for advanced breast cancer

March 30, 2004

Antitumor activity of JNJ-7706621, an orally available CDK inhibitor, demonstrated in vivo

March 29, 2004

Novel retinoid-related ligand presented by Allergan at AACR meeting

March 29, 2004

European CPMP recommends approval of Erbitux in colorectal cancer

March 29, 2004

Aventis submits new U.S. and E.U. regulatory submissions for Taxotere

March 29, 2004

New antitumor lamellarin analogues developed at PharmaMar

March 29, 2004

Synergistic action of rosiglitazone and gemcitabine observed in pancreatic cancer cell lines

March 29, 2004

Lovastatin reduces expression of ER-alpha in human breast cancer cell lines

March 29, 2004

INDs filed for topical PEP-005

March 26, 2004

New European phase II/III trial for Bexidem in bladder cancer

March 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...